By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Developing regenerative medicines1.2M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States ,the Bahamas and Israel1.2M100.00%